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Non-human primates are our closest relatives and are of special interest for ecological, evolutionary 
and biomedical research. The Japanese macaque (Macaca fuscata) has contributed to the progress 
of primatology and neurosciences over 60 years. Despite this importance, the molecular and cellular 
basis of the Japanese macaque remains unexplored since useful cellular tools are lacking. Here we 
generated induced pluripotent stem cells (iPSCs) from skin fibroblasts of the Japanese macaque with 
Sendai virus or plasmid vectors. The Japanese macaque iPSCs (jm-iPSCs) were established under feeder-
free culture conditions, but feeder cells turned out to be essential for their maintenance. The jm-iPSCs 
formed human iPSC-like flat colonies which were positive for pluripotent antigens including alkaline 
phosphatase, SSEA4, and TRA-1-81. They also expressed endogenous OCT3/4, SOX2, L-MYC, and KLF4 
and other pluripotent marker genes. The potential to differentiate into all three germ layers and neural 
stem cells was confirmed by embryoid body and neurosphere formation, respectively. The jm-iPSCs 
will provide a robust in vitro tool for investigating the underlying mechanisms of development and 
physiology studies with the Japanese macaque.
The Japanese macaque (Macaca fuscata) is one species of the Asian macaque monkeys along with rhesus and 
cynomolgus monkeys. The Japanese macaque - also known as the snow monkey - is native to Japan and is the 
most northern living non-human primate species. Historically, field researchers have studied social behavior and 
ecology of the Japanese macaque for more than half a century for religious reasons, leading to the pioneering 
of primatology in Japan1–3. The Japanese macaque also has attracted researcher’s attention in laboratories as a 
valuable experimental animal model due to their anatomical and physiological similarities to humans, their high 
cognitive ability, and their gentle and patient character4. Especially, the Japanese macaque has contributed to the 
advance of neuroscience5 through the investigations of brain activity and cognition6–9, neural pathway and gene 
expression10,11, and spontaneous mutant monkeys12–15. From the above, the Japanese macaque has been employed 
as an excellent primate model with the accumulated knowledge and a potential to integrate the laboratory stud-
ies with the field research. However, difficulties in developmental physiology and genetic manipulations in vivo 
restrict in-depth analyses of molecular and cellular mechanisms in the Japanese macaque biology.
Induced pluripotent stem cells (iPSCs) can provide a new strategy to compensate this experimental concern 
of the Japanese macaque. iPSCs are a new type of pluripotent stem cells that have revolutionized stem cell biol-
ogy and medicine16,17 and have a huge potential for evolutionary and comparative genomic approaches18–26. As 
pluripotent stem cells, iPSCs have a potential to differentiate into all three germ layers (ectoderm, mesoderm, and 
endoderm) and germ cells both in vivo and in vitro. Technically, iPSCs are regarded to have four experimental 
advantages in research. First, iPSCs can be generated from many different types of small biopsies of mammalian 
species with relatively simple protocols26–28. Second, iPSCs have robust and infinite proliferation activity while 
self-renewing. Third, iPSCs can reconstruct developmental events of interest in vitro, providing alternatives for 
invasive study using animal individuals. Fourth, iPSCs are amenable to genetic manipulations including genome 
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editing. Thus, iPSCs can serve as a potent in vitro tool to address the molecular and cellular basis of development 
and physiology in the Japanese macaque.
In this study, we generated the Japanese macaque iPSCs (jm-iPSCs) from skin fibroblasts by transducing a set 
of human reprogramming factors with Sendai virus (SeV)27 or plasmid28,29 vectors. The jm-iPSCs were similar 
with human iPSCs in colony morphology, marker gene expression, and differentiation potency albeit their growth 
totally depended on feeder cells. Embryoid body and neurosphere formation cultures induced differentiation of 
the jm-iPSCs spontaneously into three germ layers or specifically into neural stem cells respectively. The jm-iPSCs 
will be a powerful in vitro counterpart to facilitate the Japanese macaque biology.
Materials and Methods
Ethics. All experiments using primate samples in this study were approved by the Animal Care and Use 
Committee of Kyoto University Primate Research Institute (KUPRI) and were performed in accordance with the 
Guidelines for Care and Use of Nonhuman Primates (Version 3, 2010) published by KUPRI.
Generation of jm-iPSCs by Sendai virus vector infection and plasmid vector transduc-
tion. Japanese macaque skin fibroblasts (jm1481, 21-year-old female; jm2623, 6-day-old female) were cultured 
in the 15%FBS/DMEM medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
15% fetal bovine serum (FBS), 0.1 mM non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, 
0.11 mM 2-mercaptoethanol, and 100 U/ml penicillin and 100 µg/ml streptomycin at 37 °C with 5% CO2.
SeV infection was performed using CytoTune-iPS 2.0 L (MBL, DV-0305) with a modified protocol. Briefly, 
1 × 105 jm-fibroblasts were incubated in 100 μl of SeV mixture containing KOS(PM)-SeV/TS12ΔF, KLF4-SeV/
TSΔF, and L-MYC(HNL)-SeV/TS15ΔF at a multiplicity of infection 5, 5, and 10 each at 37 °C for 1 hour. To 
assess the successful transduction, CytoTune-EmGFP SeV was also infected. The infected 5 × 104 cells were plated 
to the iMatrix 511-coated 6-well plates (day 0). The SeV-containing medium was exchanged to fresh 15%FBS/
DMEM on day 1. For plasmid transfection, 1 × 105 jm-fibroblasts were transfected with pCXLE-hOct3/4-shp53-F, 
pCXLE-hSK, pCXLE-hUL28 and pCXWB-EBNA129 by Lipofectamine 3000 (Thermo Fisher Scientific, L3000). 
pCXLE-EGFP was used as a transfection control. After 6 days of culture with 15%FBS/DMEM, 5 × 104 cells were 
replated to the iMatrix 511 (Matrixome, 389-07364)-coated 35-mm plates.
In both cultures, the medium was exchanged to mTeSR1 (StemCell Technologies, ST0580) on day 7 and medium 
change was performed every other day. The resulting iPSC-like colonies were mechanically isolated and incubated 
with TrypLE Select (Life Technologies, 12563029). The cells were plated to iMatrix 511-coated plates and cultured 
with StemFit (Ajinomoto, AK02N) supplemented with 10 μM of Y-27632 (Wako, 253-00513). After several passages, 
the jm-iPSCs were maintained on mitomycin-treated SNL feeder cells with StemFit at 37 °C with 5% CO2
Chromosome analysis. The jm-iPSCs at a 70~80% confluency were treated with 50 ng/ml colcemid for 
40 minutes. The cells were harvested by TrypLE Express, treated with 0.56% KCl for 20 minutes at room temper-
ature, and fixed with ethanol-acetic acid (3:1) for 10 minutes on ice30. Chromosome spreads were prepared with 
one drop of fixed cell suspension. After treatment with 0.05% IGEPAL CA-630, the chromosome samples were 
stained with ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific, P36966). Karyotyping 
of chromosomes was performed according to the previous report31.
Alkaline phosphatase, rBC2LCN lectin, and immunofluorescence analyses. Alkaline phosphatase 
staining and rBC2LCN live cell staining was performed using Leukocyte Alkaline Phosphatase kit (Sigma, 
86R-1KT) and rBC2LCN-FITC (Wako, 180-02991) respectively, according to the manufacture’s instructions. 
For immunofluorescence microscopy, cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% 
Triton-X, blocked with 5% skim milk, and incubated with primary antibodies. The following primary antibod-
ies were used: mouse anti-OCT4 (BD Biosciences, 611202), rabbit anti-NANOG (REPROCELL, RCAB0003P), 
goat anti-LIN28A (R&D systems, AF3757), rabbit anti-DPPA4 (Abcam, ab154642), mouse anti-SOX2 (R&D 
systems, MAB2018), rabbit anti-SALL4 (Abcam, ab29112), mouse anti-SSEA4 (Millipore, MAB4304), mouse 
anti-TRA-1-81 (Millipore, MAB4381), mouse anti-E-CADHERIN (BD Biosciences, 610182), mouse anti-Keratan 
sulfate (R-10G) (Wako, 011-25811), mouse anti-TUBULIN β3 (BioLegend, MMS-435P), mouse anti-α-SMA 
(Abcam, ab7817), rabbit anti-VIMENTIN (Abcam, ab92547), goat anti-SOX17 (R&D systems, AF1924), mouse 
anti-AFP (R&D systems, MAB1369), mouse anti-NESTIN (Millipore, MAB5326), rabbit anti-PAX6 (Wako, 019-
27291), rabbit anti-MAP2 (Millipore, AB5622), mouse anti-DREBRIN (Wako, 015-27271) antibodies. Secondary 
antibodies included Alexa Fluor Plus 488 goat anti-mouse IgG (Thermo Fisher Scientific, A32723), Alexa Fluor 
488 donkey anti-goat IgG (Thermo Fisher Scientific, A11055), Alexa Fluor 555 donkey anti-mouse IgG (Abcam, 
ab150110), Alexa Fluor 555 donkey anti-rabbit IgG (Thermo Fisher Scientific, A31572). Nuclei were stained with 
1 µg/ml DAPI.
RT-PCR and PCR analyses. Total RNA was extracted using RNeasy Plus Mini Kit (Qiagen, 74104) and 
reverse transcribed using the PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, RR047A). Genomic DNA 
was isolated using DNeasy Blood & Tissue Kit (Qiagen, 69506). RT-PCR and PCR analyses were performed with 
Ex Taq Hot Start Version (TaKaRa, RR006A). All experiments were performed semiquantitatively at three differ-
ent escalation cycles, and only representative images are shown in the result.
In vitro differentiation culture. For embryoid body (EB) formation, jm-iPSCs were dissociated and trans-
ferred to 6-well low attachment culture plates (corning) at 1 × 106 cells/ml in 15%FBS/DMEM. After 2 weeks 
culture, the EBs were transferred to Geltrex-coated plates and cultured at an adhesion condition with 15%FBS/
DMEM for another 3 weeks.
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For directed differentiation into neural stem cells, jm-iPSCs were transferred to 6-well low attachment plates 
in KBM Neural Stem Cell medium (Kohjin Bio, 16050200) supplemented with 2 μM dorsomorphin (Cayman, 
11967), 10 μM SB431542 (Cayman, 13031), and 1 × B-27 (Gibco, 17504-044) at 1.5 × 105 cells/ml. Soon after iPSC 
dissociation, 10 μM Y-27632 was added to the medium. On day 1 and 4, 3 ng/ml Stembeads FGF2 (StemCultures, 
SB500) were added into the medium and the medium was half-exchanged on day 4. To induce neuronal differ-
entiation, 1-week old neurospheres were plated onto Geltrex-coated culture plates and cultured in KBM Neural 
Stem Cell medium without FGF2 and EGF but supplemented with 1 × B-27 for 2 weeks.
Results
To generate jm-iPSCs from primary skin fibroblasts (jm1481, jm2623), we applied two methods to transduce the 
reprogramming factors with SeV27 and plasmid28,29 vectors (Fig. 1a). Human POU5F1 (also known as OCT3/4), 
SOX2, KLF4, and L-MYC were transduced into jm-fibroblasts by SeV infection, while plasmid vectors bearing 
human OCT3/4, SOX2, KLF4, LIN28, L-MYC, and shRNA for TP53 were transfected with an additional EBNA1 
plasmid by lipofection. In both cultures, the expression of GFP transgenes showed successful gene transduc-
tion into jm-fibroblasts albeit the transduction efficiency was much lower in the plasmid transfection (Fig. 1b). 
iPSC-like colonies appeared from jm2623 fibroblasts within 15 days after SeV infection and 25 days after plasmid 
transfection. Since jm1481 fibroblasts had a tendency to detach within 3 weeks after vector transduction, we 
re-plated the cells to a new plate on day 19. Human iPSC-like flat and clear-edged colonies were mechanically 
dissected and plated onto new dish on day 25 (jm2623 fibroblasts) or day 32 (jm1481 fibroblasts) (Fig. 1c).
Although the jm-iPSC colonies emerged under feeder-free culture, feeder cells were required to maintain the 
jm-iPSCs in an undifferentiated state. The jm-iPSCs grown on feeder cells formed flat and tightly packed colonies 
with sharp edges, while cells under feeder-free culture gradually exhibited loose colonies showing a heterogenous 
alkaline phosphatase staining after serial passages (Fig. 1d). Mouse SNL cells or autologous jm-fibroblasts were 
effective as feeder cells therefore we utilized SNL cells because of its technical convenience. The jm-iPSCs could 
be expanded for more than 50 passages.
For characterization of the jm-iPSCs established, we used two different jm-iPSC lines J5F1 (derived from 
SeV-jm1481) and J9F2 (derived from plasmid-jm2623). SeV vectors replicate their RNA genomes in the cyto-
plasm of infected cells. During reprogramming, SeV vectors are gradually diluted but can sometimes be detected 
even in established iPSCs27. In J5F1 jm-iPSCs, no residual SeV vectors were detected by RT-PCR (Fig. 1e). We also 
performed PCR to detect plasmid transgenes in the established iPSC lines and identified a genomic integration of 
OCT3/4, L-MYC, LIN28, and EBNA1 in J9F2 jm-iPSCs (Fig. 1f).
The jm-iPSCs had normal karyotype (42 XX) (Fig. 2a, Supplementary Figure S3a). The jm-iPSCs were 
strongly positive for rBC2LCN lectin32 staining (Fig. 2b, Supplementary Figure S3b). Immunofluorescence 
analyses showed that the jm-iPSCs expressed other pluripotency intracellular antigens (OCT3/4, NANOG, 
LIN28, DPPA4, SOX2, SALL4) (Fig. 2c, Supplementary Figure S3c) and cell surface antigens (SSEA4, TRA-1-
81, E-CADHERIN) (Fig. 2d, Supplementary Figure S3d). R-10G sugar chain epitope33 was also detected in the 
jm-iPSCs, indicating that the jm-iPSCs were highly reprogrammed pluripotent stem cells. RT-PCR revealed the 
expression of a set of pluripotency-associated genes, such as REX1, GDF3, and TERT, in the jm-iPSCs but not 
in the parental fibroblasts (Fig. 2e). The endogenous expression of OCT3/4, SOX2, L-MYC, and KLF4 was also 
induced in the jm-iPSCs. The expression of XIST showed that X chromosome reactivation did not occur in these 
female jm-iPSCs, suggesting their primed pluripotency.
Differentiation potency of jm-iPSCs was examined by embryoid body (EB) and neurosphere forma-
tion cultures. In EB formation culture, jm-iPSCs formed ball-like structures at a floating condition (Fig. 3a,b, 
Supplementary Figure S4a). When transferred to the adherent culture, the EBs expanded and various kinds of 
differentiated cells appeared spontaneously (Fig. 3c, Supplementary Figure S4b). Immunofluorescence analy-
sis revealed differentiation to the ectoderm (TUJ1), mesoderm (α-SMA, VIMENTIN), and endoderm (SOX17, 
AFP) lineage in the EB outgrowth (Fig. 3d, Supplementary Figure S4c). The expression of the three germ layer 
markers in the EBs was also detected by RT-PCR analysis (Fig. 3e, Supplementary Figure S4d). However, com-
pared to J5F1 jm-iPSCs, J9F2 jm-iPSCs were likely to have less differentiation potency. Then, neurosphere forma-
tion culture34–36 demonstrated the ability to directed differentiation into neural stem cells (Fig. 4a). The jm-iPSCs 
formed neurospheres in the presence of chemical dual SMAD inhibitors37 during 1-week floating culture (Fig. 4b, 
Supplementary Figure S5a). The neurospheres were then cultured at a neuronal differentiation condition for 
another 2 weeks (Fig. 4c, Supplementary Figure S5b). Immunofluorescence analysis detected the efficient pro-
duction of neural stem cells (NESTIN+, PAX6+) and neurons (TUJ1+, MAP2+, DREBRIN+) in the differentiated 
neurospheres (Fig. 4d, Supplementary Figure S5c). Again, RT-PCR analysis also revealed the expression of neural 
stem/progenitor cells (GLAST, ASCL1 etc.) and neuron markers (DCX, VGLUT2 etc.) after neuronal differentia-
tion of the neurospheres (Fig. 4e, Supplementary Figure S5d).
Discussion
Here, we generated jm-iPSCs from adult and neonate skin fibroblasts by transducing human reprogramming 
factors with Sendai virus and plasmid vectors. Once established, the jm-iPSCs formed tight and flat colonies sim-
ilarly to human iPSCs and grew over 50 passages. They expressed the pluripotency-associated genes and exhib-
ited differentiation potency into all three germ layers. Basic molecular and cellular properties of the jm-iPSCs 
seemed to be similar with those of human iPSCs. To date, numerous number of methods have been developed to 
induce directed differentiation from human iPSCs into cell types of interest in vitro, and, among them, neuros-
phere formation culture36,37 could be applied to the jm-iPSCs to derive neural stem cells (Fig. 4, Supplementary 
Figure S5). Thus, in vitro differentiation protocols for human iPSCs are expected to be applicable to the jm-iPSCs. 
Experimental platforms have been set up to study in vitro developmental biology of the Japanese macaque and 
comparative Evo-Devo studies among primate species including human.
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Figure 1. Generation of jm-iPSCs from skin fibroblasts (a). Schematic design of jm-iPSC generation. SeV, 
Sendai virus system. Pla, plasmid vector system. (b) The expression of GFP transgenes in jm-fibroblasts 
(jm2623) on day 3 after SeV (upper) and plasmid vector (lower) transduction. Scale bar; 100 µm. (c) Phase 
contrast images of iPSC-like colony morphologies emerged from jm2623 (day 25, upper; SeV, lower; plasmid) 
and jm1481 fibroblasts (day 32, SeV). Scale bar; 100 µm. (d) Phase contrast images of jm-iPSCs (J5F1, derived 
from SeV-jm1481) grown on feeder cells or under feeder-free culture after staining for alkaline phosphatase. 
Scale bar; 500 µm. (e) RT-PCR analysis of SeV vectors. Jm-fibroblasts (jm1481) infected with SeV vectors 
carrying GFP or reprogramming factors (KOSL, day 3) were used as positive controls of SeV vectors. β-ACTIN 
was examined as an internal control. Full-length gels are presented in Supplementary Figure S1. (f) Genomic 
PCR analysis of plasmid transgenes. Each plasmid vector carrying reprogramming factors and water were used 
as a positive and negative control, respectively. An hCONDEL region was examined as an internal control. Full-
length gels are presented in Supplementary Figure S1.
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Although jm-iPSCs could be cultured basically referring to human iPSC protocols, Japanese macaque fibro-
blasts were not highly competent for lipofection-based gene transduction (Fig. 1b). In addition, feeder cells 
were necessary for long term maintenance of the jm iPSCs. For feeder-free culture of the jm-iPSCs, we used 
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Figure 2. Molecular characterization of jm-iPSCs (J5F1) (a). Chromosomal analysis of jm-iPSCs (J5F1). 
Scale bar; 10 µm. (b) Live staining of jm-iPSCs (J5F1) with rBC2LCN lectin. Scale bar; 200 µm. (c) 
Immunofluorescence analyses of pluripotency-associated proteins OCT4, NANOG, LIN28, DPPA4, SOX2, and 
SALL4. (d) Immunofluorescence analyses of pluripotency-associated cell surface antigens SSEA4, TRA-1-81, 
E-CADHERIN, and R-10G. Nuclei were counterstained with DAPI. Scale bar; 250 µm. (e) RT-PCR analyses of 
pluripotency-associated genes. β-ACTIN was examined as an internal control, and water was used as a negative 
control. Full-length gels are presented in Supplementary Figure S1.
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laminin-511 E8 coating in combination with StemFit medium that enables efficient feeder-free expansion of 
human iPSCs even after single cell dissociation38. We further assessed additional molecules (ID-839, GF109203X40, 
increased concentration of FGF2 etc.) or other coating reagents (Geltrex etc.), but none of them improved the 
feeder-free culture of jm-iPSCs (data not shown). Therefore, current feeder-free cultures that have devised for 
human iPSCs are not sufficient to maintain jm-iPSCs. It remains unclear whether this is due to species-specific 
cell culture requirements or cellular properties including reprogramming quality. To achieve a conventional 
feeder-free culture of jm-iPSCs, further investigations of culture conditions, including optimization for macaque 
monkeys rather than human, will be needed.
Mouse and human iPSC studies have revealed that reprogramming efficiency declines in a donor 
age-dependent manner41. Indeed, albeit jm-iPSCs could be generated from 6-day-old neonate (jm2623) and 
21-year-old adult (jm1481) donor monkeys, the neonate showed a much higher amount of iPSC colonies upon 
reprogramming than the adult macaque (data not shown). It is also suggested that age-related genetic and epige-
netic signatures inherited from donor cells may influence the quality of iPSCs42. When we compared the jm-iPSC 
lines J5F1 and J9F2, the differentiation potency seemed to be higher in adult-derived J5F1 than neonate-derived 
J9F2 iPSCs (Fig. 3, Supplementary Figure S4). Considering the low transduction efficiency and the genomic 
integration of transgenes in the plasmid transfection-derived iPSCs (Fig. 1b,f), the differences are likely to be 
explained by the transduction method and subsequent reprogramming quality rather than the donors age. To 
assess the effects of donor age and gene transduction methods on reprogramming in the Japanese macaque, it is 
necessary to characterize several jm-iPSC lines derived from various donors with different ages and reprogram-
ming methods.
To date, several spontaneous mutant monkeys have been found in the Japanese macaque populations. For 
example, a child monkey in our institute was characterized by significant premature aging that exhibited common 
symptoms with human progeria, including deep skin wrinkles, cataract, poikiloderma, and shrinkage of cerebral 
cortex12. To identify the genes associated with these phenotypes, genomic DNA sequencing of this monkey was 
performed. However, no mutations in known genes that are responsible for the major human progeroid syn-
dromes were detected so that the molecular basis underlying the premature aging remained unclear. In another 
case, a monkey that exhibited an autism spectrum disorder was reported14. This monkey exhibited impaired 
social ability, repetitive behaviors, and less neurons responsive to other monkey’s action. Genomic analyses of 
copy number variation and exome sequencing identified many mutations unique to this monkey including two 
genes associated with neuropsychiatric disorders in humans; however it remains to be determined whether these 
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Scale bar; 200 µm. (c) Outgrowth of jm-iPSC (J5F1)-derived EBs at 3-week adherent culture. Representative 
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genes are actually causal for the phenotype. To fill the gap between phenotype and genotype, the jm-iPSCs from 
mutant monkeys are useful for in-depth, comprehensive analyses as demonstrated by disease-specific iPSCs in 
human43. Directed differentiation of mutant monkey jm-iPSCs enables researchers to model the pathophysiology 
and investigate its underlying mechanisms in vitro. Furthermore, functional assays of genetically manipulated 
candidate genes will give insight to their contribution to molecular circuits and cellular properties. This approach 
can be applied to wild type monkeys and a wide range of different primates as well, and intensively support neu-
rosciences from the point of view of molecular, cellular, and developmental biology.
A recent study reported that approximately 60% of non-human primate species is under the risk of extinction 
and approximately 75% of the populations are decreasing in size44. To address this issue, multilateral efforts and 
solutions including preservation of their habitats or artificial breeding are needed. Given the technical advantages 
of iPSCs which are easy to generate and proliferate infinitely, the iPSC technology will serve as a backup system 
to preserve divergent bio-resources. For example, the establishment of a primate iPSC bank as a ‘frozen zoo’ is 
useful for keeping invaluable genetic materials in a viable condition45. Furthermore, considering recent progresses 
of germ cell production from iPSCs46, iPSCs-derived germ cells are likely to be a more direct means for future 
assisted reproduction. Primate iPSCs would provide a new strategy for conservation and reproduction of primate 
species, and the Japanese macaque and jm-iPSCs could be a good model for this challenge. This is also helpful 
to preserve bio-resources of the rare spontaneous mutant monkeys that are found incidentally in populations.
In conclusion, we generated iPSCs from the Japanese macaque fibroblasts with a reprogramming strategy 
optimized for human iPSCs. This new in vitro system would contribute to further development of primatology 
and neurosciences by facilitating the molecular and cellular understanding of Japanese macaque.
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length gels are presented in Supplementary Figure S2.
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